2.14
0.34 (18.89%)
0.34 (18.89%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Timber Pharmaceuticals Inc | TMBR | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.34 | 18.89% | 2.14 | 12:21:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.95 | 1.90 | 2.27 | 1.80 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,642 | 3,220,460 | $ 2.10 | $ 6,758,903 | 6,737,206 | 0.6651 - 4.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:21:51 | 50 | $ 2.13 | USD |
Timber Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 25.36M | 11.85M | 11.85M | $ 270.54k | $ - | -0.26 | -0.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Timber Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMBR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.07 | 2.33 | 1.42 | 1.90 | 6,308,069 | 0.07 | 3.38% |
| 1 Month | 1.28 | 3.15 | 1.16 | 2.09 | 8,645,708 | 0.86 | 67.19% |
| 3 Months | 1.11 | 3.15 | 0.6651 | 1.46 | 7,455,727 | 1.03 | 92.79% |
| 6 Months | 1.25 | 3.15 | 0.6651 | 1.43 | 3,646,697 | 0.89 | 71.2% |
| 1 Year | 4.11 | 4.17 | 0.6651 | 1.55 | 2,664,839 | -1.97 | -47.93% |
| 3 Years | 4.11 | 4.17 | 0.6651 | 1.55 | 2,664,839 | -1.97 | -47.93% |
| 5 Years | 4.11 | 4.17 | 0.6651 | 1.55 | 2,664,839 | -1.97 | -47.93% |
Timber Pharmaceuticals Description
| Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist). |
